🔎 Trials Near Me

Početna › Krvarenje › Kalifornija

Kliničke studije za Krvarenje u državi Kalifornija

12 studija za Krvarenje traži sudionike na lokacijama u državi Kalifornija.

Gradovi u državi Kalifornija

Službeni tekst studije (engleski)

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

  • The Regents of the University of California||UC Davis Health, Rancho Cordova
  • UC Davis Health, Sacramento
  • UC Davis Ambulatory Care Clinic, Sacramento
  • i još 3
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 2. lis 2026. · NCT05568719

CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial

  • Zuckerberg San Francisco General Hospital and Trauma Center at University of California, San Francisco, San Francisco
U tijeku regrutacijaFaza 2
Od 18 do 90 godina · Oba spola · Ažurirano 29. ruj 2026. · NCT05958342

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

  • Mission Cardiovascular Research Institute, Fremont
  • National Institute of California Heart and Vein Specialists, Huntington Beach
  • Profound Research LLC at San Diego Cardiovascular Associates, La Jolla
  • i još 5
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07626411

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

  • Valley Clinical Trials, Inc, Covina
  • North Coast Cardiology, Encinitas
  • Mission Cardiovascular Research Institute, Fremont
  • i još 7
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07175428

Onyx™ Liquid Embolic IDE Clinical Study

  • University of California, Irvine, Irvine
  • Stanford Medical Center, Palo Alto
U tijeku regrutacija
Od 22 godina i više · Oba spola · Ažurirano 21. ruj 2026. · NCT06742801

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
  • University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 18. ruj 2026. · NCT06722235

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
  • University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT06948318

Oxytocin Pharmacokinetics and Pharmacodynamics

  • Stanford University, Stanford
U tijeku regrutacijaFaza 2
Od 18 do 50 godina · Žene · Ažurirano 21. kol 2026. · NCT05488457

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

  • Lucile Packard Children's Hospital, Palo Alto
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 0 do 20 godina · Oba spola · Ažurirano 21. kol 2026. · NCT04278404

A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery

  • Torrance Memorial, Torrance
U tijeku regrutacijaFaza 3
1 Month · Oba spola · Ažurirano 30. lip 2026. · NCT06664775

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

  • University of Southern California, Los Angeles
  • Cedars-Sinai Medical Center, Los Angeles
  • Stanford University, Stanford
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 26. lip 2026. · NCT04045665

Tranexamic Acid for Second Trimester Dilation and Evacuation and Bleeding Outcomes

  • University of California San Diego, San Diego
  • Planned Parenthood of the Pacific Southwest, San Diego
U tijeku regrutacijaFaza 4Zdravi dobrovoljci dobrodošli
Od 18 godina i više · Žene · Ažurirano 15. lip 2026. · NCT06820177

Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.